AIA Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-74,815
| Closed | -$2.18M | – | 305 |
|
|
2024
Q3 | $2.18M | Buy |
74,815
+5,471
| +8% | +$159K | 0.06% | 150 |
|
|
2024
Q2 | $1.61M | Buy |
69,344
+8,310
| +14% | +$193K | 0.05% | 178 |
|
|
2024
Q1 | $1.25M | Sell |
61,034
-7,044
| -10% | -$145K | 0.04% | 189 |
|
|
2023
Q4 | $1.46M | Sell |
68,078
-369
| -0.5% | -$7.92K | 0.06% | 152 |
|
|
2023
Q3 | $1.41M | Buy |
68,447
+12,203
| +22% | +$252K | 0.07% | 133 |
|
|
2023
Q2 | $1.66M | Buy |
56,244
+5,980
| +12% | +$176K | 0.08% | 122 |
|
|
2023
Q1 | $1.16M | Buy |
50,264
+27,502
| +121% | +$634K | 0.06% | 136 |
|
|
2022
Q4 | $633K | Sell |
22,762
-14,264
| -39% | -$397K | 0.04% | 200 |
|
|
2022
Q3 | $1.14M | Sell |
37,026
-38
| -0.1% | -$1.17K | 0.07% | 111 |
|
|
2022
Q2 | $1.09M | Sell |
37,064
-4,321
| -10% | -$127K | 0.06% | 146 |
|
|
2022
Q1 | $1.33M | Sell |
41,385
-66,457
| -62% | -$2.14M | 0.06% | 145 |
|
|
2021
Q4 | $4.81M | Buy |
107,842
+9,401
| +10% | +$419K | 0.23% | 59 |
|
|
2021
Q3 | $4.97M | Buy |
98,441
+16,550
| +20% | +$835K | 0.28% | 59 |
|
|
2021
Q2 | $5.3M | Buy |
81,891
+27,516
| +51% | +$1.78M | 0.36% | 50 |
|
|
2021
Q1 | $3.11M | Buy |
54,375
+17,937
| +49% | +$1.02M | 0.45% | 53 |
|
|
2020
Q4 | $2.49M | Buy |
+36,438
| New | +$2.49M | 0.29% | 53 |
|